JavaScript is disabled for your browser. Some features of this site may not work without it.
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
English
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Home
  • Contact
  • Help

Browse

All of IRISCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

Most PopularBy Country

Related Links

WPRO IRISPAHO IRIS

The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance

Thumbnail
View/Open
9789241549899-eng.pdf (‎1.434Mb)‎
View Statistics
Show Statistical Information
Altmetrics
Share
Citation
World Health Organization. (‎2016)‎. The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance. World Health Organization. http://www.who.int/iris/handle/10665/250614
Description
58 p.
ISBN
9789241549899
Collections
  • Publications
Language
English
Metadata
Show full item record

Related items

Showing items related by title and MeSH subject.

  • Thumbnail

    Target regimen profiles for TB treatment: candidates: rifampicin-susceptible, rifampicinresistant and pan-TB treatment regimens 

    World Health Organization (‎WHO/HTM/TB/2016.16, 2016)‎
  • Thumbnail

    The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis / Bjorn Blomberg ... [‎et al.]‎ 

    Blomberg, Bjorn; Spinaci, Sergio; Fourie, Bernard; Laing, Richard (‎2001)‎
  • Thumbnail

    WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis 

    World Health Organization (‎WHO/CDS/TB/2018.7, 2018)‎

Show Statistical Information

View Item 
  • IRIS Home
  • 1. Headquarters
  • Publications
  • View Item
  • IRIS Home
  • 1. Headquarters
  • Publications
  • View Item

© WHO 2017